Cargando…
SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma
An accurate diagnostic marker for detecting early-stage hepatocellular carcinoma (eHCC) is clinically important, since early detection of HCC remarkably improves patient survival. From the integrative analysis of the transcriptome and clinicopathologic data of human multi-stage HCC tissues, we were...
Autores principales: | Shen, Qingyu, Nam, Suk Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836557/ https://www.ncbi.nlm.nih.gov/pubmed/29397868 http://dx.doi.org/10.5483/BMBRep.2018.51.2.021 |
Ejemplares similares
-
Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma
por: Hwang, Hai-Min, et al.
Publicado: (2018) -
The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma
por: Parikh, Neehar D., et al.
Publicado: (2016) -
Serum small extracellular vesicle‐derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma
por: Kim, Soon Sun, et al.
Publicado: (2020) -
Could Microplastics Be a Driver for Early Onset Colorectal Cancer?
por: Li, Shelley, et al.
Publicado: (2023) -
Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression
por: Li, Wei, et al.
Publicado: (2016)